1 / 6

Neurofibromatoses Type I Von Recklinghausen's Disease Global Clinical Trials Review H2 2015

This report provides top line data relating to the clinical trials on Neurofibromatoses Type I (Von Recklinghausen's Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Our Clinical Trial Reports are generated using our proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80 different clinical trial registries, conferences, journals, news etc. across the globe. Clinical trials database undergoes periodic update by dynamic process

RamonEMarshall01
Download Presentation

Neurofibromatoses Type I Von Recklinghausen's Disease Global Clinical Trials Review H2 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neurofibromatoses Type I (Von Recklinghausen's Disease) Global Clinical Trials Review, H2, 2015 By RnRMarketResearch.com Publisher Name : GlobalData Date: 19-Aug-2015 No. of pages: 91 Single User License: US $2500 Browse more Reports on Clinical Trials at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Neurofibromatoses Type I Global Clinical Trials Review, H2, 2015 This provides an overview of Neurofibromatoses Type I (Von Recklinghausen's Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Neurofibromatoses Type I (Von Recklinghausen's Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Our Clinical Trial Reports are generated using our proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Neurofibromatoses Type I Global Clinical Trials Review, H2, 2015 Companies Discussed/Mentioned in this Research : AstraZeneca Plc, Novartis AG, ZonMw, Sarcoma Alliance for Research through Collaboration, Quintiles Transnational Holdings Inc., Pfizer Inc., Kolltan Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Daiichi Sankyo Company, Limited, Array BioPharma Inc., National Cancer Institute, University of Alabama at Birmingham, Massachusetts General Hospital, Assistance Publique - Hopitaux de Paris, Central Manchester University Hospitals NHS Foundation Trust, Centre HospitalierUniversitaire de Nantes, Erasmus MC, Foundation IRCCS Neurological Institute Carlo Besta, Hospices Civils de Lyon and Indiana University Explore More Research Report on Clinical Trial Market. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Neurofibromatoses Type I Global Clinical Trials Review, H2, 2015 Scope For Neurofibromatoses Type I Global Clinical Trials Review, H2, 2015 • The report provides a snapshot of the global clinical trials landscape • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment • The Report provides enrollment trends for the past five years • Report provides latest news for the past three months ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Neurofibromatoses Type I Global Clinical Trials Review, H2, 2015 Reasons to Buy: • Assists in formulating key business strategies with regards to investment • Helps in identifying prominent locations for conducting clinical trials which saves time and cost • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities • Supports understanding of trials count and enrollment trends by country in global therapeutics market • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials • Facilitates clinical trial assessment of the indication on a global, regional and country level ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Neurofibromatoses Type I Global Clinical Trials Review, H2, 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related